MolNFT v1 · #107049 · protein
Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease
4TYD · NS3 protease: “Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine…”. X-ray diffraction, 3 ligands (3EO, ZN, CL), 20 pockets (best druggability 0.82). MolNFT v1 #107049 on…
- PDB
- 4TYD
- Type
- protein
- Length
- 2,321 residues
- Chains
- 12
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- NS3 protease
- UniProt
- Q0ZNA6
- Ligands
- 3EO, ZN, CL
- Pockets
- 20 · best druggability 0.82
Structure
x-ray diffraction · 9 distinct chains · 14% helix, 47% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | NS3 protease | protein | 194 | 14% helix, 45% strand | Q0ZNA6 |
| B, J | NS3 protease | protein | 196 | 15% helix, 46% strand | Q0ZNA6 |
| C | NS3 protease | protein | 196 | 14% helix, 46% strand | Q0ZNA6 |
| D | NS3 protease | protein | 195 | 16% helix, 47% strand | Q0ZNA6 |
| E, G | NS3 protease | protein | 190 | 12% helix, 47% strand | Q0ZNA6 |
| F, M | NS3 protease | protein | 195 | 14% helix, 46% strand | Q0ZNA6 |
| H | NS3 protease | protein | 193 | 16% helix, 46% strand | Q0ZNA6 |
| K | NS3 protease | protein | 194 | 13% helix, 47% strand | Q0ZNA6 |
| L | NS3 protease | protein | 187 | 11% helix, 49% strand | Q0ZNA6 |
Ligands and binding sites
- 3EO · (4R,6S,7Z,15S,17S)-17-[({7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)methyl]-13-methyl-N-[(1-methylcyclopropyl)sulfonyl]-2,14-dioxo-1,3,13-triazatricyclo[13.2.0.0~4,6~]heptadec-7-ene-4-carboxamide · ligand · 12 copies · chains A, D, B, E, C, F, G, M, H, J, L, K
- ZN · Zinc ion · metal · 12 copies · chains A, B, C, D, E, F, G, H, J, K, L, M
- CL · Chloride ion · ion · 11 copies · chains A, B, C, E, D, F, G, H, M
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
20 pockets found on a 1 Å grid, 19 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 430 | 0.82 | 0.90 | 78 | CL |
| 2 | 747 | 0.81 | 0.84 | 84 | empty |
| 3 | 466 | 0.81 | 0.88 | 64 | empty |
| 4 | 460 | 0.79 | 0.87 | 74 | empty |
| 5 | 359 | 0.74 | 0.86 | 56 | empty |
Interfaces
25 interfaces between chains.
- C–F · 470 Ų buried · 8 hydrogen bonds · protein-protein
- A–D · 465 Ų buried · 2 hydrogen bonds · protein-protein
- G–H · 458 Ų buried · 1 hydrogen bond · protein-protein
- A–F · 418 Ų buried · 1 hydrogen bond · protein-protein
- C–E · 416 Ų buried · 1 hydrogen bond · protein-protein
Compared structures
- 4TYD · Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q0ZNA6
- Elsewhere: RCSB PDB 4TYD · PDBe 4TYD · UniProt Q0ZNA6
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.